Numira Revenue and Competitors
Estimated Revenue & Valuation
- Numira's estimated annual revenue is currently $1.4M per year.
- Numira's estimated revenue per employee is $155,000
Employee Data
- Numira has 9 Employees.
- Numira grew their employee count by -10% last year.
Numira's People
Name | Title | Email/Phone |
---|
Numira Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.8M | 5 | -17% | N/A | N/A |
#2 | $1.4M | 9 | -10% | N/A | N/A |
#3 | $5.9M | 38 | 41% | N/A | N/A |
#4 | $1.1M | 7 | -53% | N/A | N/A |
#5 | $1.6M | 10 | 11% | N/A | N/A |
#6 | $21.2M | 137 | 10% | N/A | N/A |
#7 | $1.6M | 33 | -48% | $17.8M | N/A |
#8 | $1.9M | 12 | 0% | N/A | N/A |
#9 | $3.7M | 24 | 9% | N/A | N/A |
#10 | $0.9M | 6 | 0% | N/A | N/A |
What Is Numira?
Numira is a specialty preclinical CRO that combines innovative technologies and expertise to provide unique solutions to a wide variety of preclinical drug discovery efforts. We support leading pharmaceutical, biotech, and medical device companies in the areas of discovery research and efficacy evaluation, offering services in the following areas: High-Resolution MicroCT Imaging Image Analysis (microCT, MRI, ECG, histology data) Specialized Histology (GLP or non-GLP) 3D Oncology Cell Screening Utilizing our patented imaging reagents and powerful 3D visualization and analytic tools, we provide images, metrics, and analyses that will allow definitive answers much more rapidly and accurately than ever before, saving your team valuable time and resources. Therapeutic areas include: Inflammation, pulmonary, musculoskeletal, ocular, oncology, cardiovascular, CNS, devices.
keywords:N/AN/A
Total Funding
9
Number of Employees
$1.4M
Revenue (est)
-10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.7M | 9 | -10% | N/A |
#2 | $0.7M | 9 | 0% | N/A |
#3 | $0.7M | 9 | 0% | N/A |
#4 | $0.7M | 9 | -10% | N/A |
#5 | $0.7M | 9 | 0% | N/A |